Authorisations granted for uses of bis(2-methoxyethyl) ether (diglyme)

Publié le 03.06.2019

The European Commission has granted authorisations for bis(2-methoxyethyl) ether (diglyme) (review period expiry dates in brackets) for:

• one use to Roche Diagnostics GmbH (22 August 202); and
• one use to Life Technologies AS (22 August 2029).